Skip to content
Recall Observatory FDA recall evidence

Drug product

Prempro (Conjugated Estrogen/Medroxyprogesterone Acetate) tablets 0.625 mg/2.5 mg, 1 blister card containing 28 tablets, Rx only, Wyeth Pharmaceuticals Inc., Philadelphia, PA, NDC 0046-0875-11

D-630-2013

May 31, 2013

Class III

Product summary

Firm
Pfizer Inc.
Event
Event 65393
Status
Terminated
Classification
Class III
Quantity
432,657 blister cards
Official record key
drug-enforcement:D-630-2013

Official wording

Reason: Failed Dissolution Specifications: Pfizer Inc. is recalling PREMPRO (conjugated estrogens/medroxyprogesterone acetate tablets) because certain lots for this product may not meet the dissolution specification for conjugated estrogens.

Code information: Lots: E67324 & E96152 Exp: 06/13

Distribution pattern: Nationwide and Puerto Rico

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Failed Dissolution Specifications